PCA3 and posterior cortical atrophy: Recent studies have revealed lncRNAs like prostate cancer antigen 3 (PCA3), second chromosome locus associated with prostate-1 (SChLAP1), and PCa associated non-coding RNA transcripts (PCATs) as potential prognostic biomarkers.